B+
Bull case
20%
Probability
Target price
$182.96
+17.1% vs current
Consensus leans modestly positive versus the anchor with dispersed targets; near-term sentiment will hinge on quarterly results and guidance.
No evidence quality warning is currently attached to this memo.
Quarterly results and management guidance that can re-price shares versus consensus; IR has not published a date so modeling uses a conservative estimate.
Pricing and cost actions flagged by management could stabilize margins; confirmation via results or guidance would be a catalyst.
History of acquisitive growth and sector consolidation raise the chance of bolt-on deals or strategic partnerships; timing uncertain.
No formal recommendation provided.